The US Food and Drug Administration approved Gilead Sciences Inc.’s antiviral therapy Remdesivir on Thursday, granting broad clearance for the coronavirus treatment.
Regulators had granted an emergency-use authorization for Remdesivir earlier this year, and since then the drug has become a widely used therapy in hospitalized COVID-19 patients. It was given to President Trump this month when he was diagnosed with the virus.
Read the full story on BostonGlobe.com.
|
|
|
|
|
We have lots of e-mail newsletters on a variety of topics, including news, politics, business, sports, lifestyle, and more. They're free, and it's easy to subscribe. Here's a complete list.
|
|
|
|
